Delaying Heart Stents During Valve Replacement Shows Promise in Major Trial
Large randomized trial tests whether deferring coronary stents during TAVI procedures is safe and effective for heart patients.
3381 articles
Large randomized trial tests whether deferring coronary stents during TAVI procedures is safe and effective for heart patients.
Decade-long trial reveals new insights on post-stent medication strategies beyond traditional aspirin therapy.
Women experiencing early menopause face significantly higher cardiovascular disease risk, according to new research published in JAMA.
Trastuzumab deruxtecan demonstrates potential benefits in treating residual HER2-positive early breast cancer patients.
Updated practice guidelines aim to improve safety and consistency of sedation techniques used outside operating rooms.
Global study of 2+ million people reveals how hypertension, diabetes, smoking, obesity and high cholesterol dramatically reduce lifespan.
New composite index combining triglyceride-glucose levels with frailty scores dramatically improves cardiovascular risk prediction in older adults.
AI analysis of 282 patients reveals specific inflammatory markers that can predict coronary heart disease risk in people with fatty liver disease.
Engineered immune cell vesicles first induce cancer cell senescence with chemo, then eliminate them with targeted senolytic drugs.
New study reveals brain blood vessel aging as key driver of memory loss, with senolytic drugs showing promise for reversal.
Natural compounds like quercetin eliminate harmful senescent cells in the uterus, improving decidualization and reducing migration linked to endometriosis.
Removing senescent cells after flu infection accelerated lung repair and prevented chronic damage in mice.